{
  "meta": {
    "title": "Cardiomyopathies",
    "url": "https://brainandscalpel.vercel.app/cardiomyopathies-1ebb3f91.html",
    "scrapedAt": "2025-11-30T11:12:48.266Z"
  },
  "questions": [
    {
      "id": 1,
      "choices": [
        {
          "id": 1,
          "text": "<p><span style=\"font-size:12.0pt;\">Ramipril </span></p>"
        },
        {
          "id": 2,
          "text": "<p><span style=\"font-size:12.0pt;\">Frusemide</span></p>"
        },
        {
          "id": 3,
          "text": "<p><span style=\"font-size:12.0pt;\">Aspirin</span></p>"
        },
        {
          "id": 4,
          "text": "<p><span style=\"font-size:12.0pt;\">Metoprolol</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 40-year-old man presents with a history of dyspnoea and palpitations. On examination he has a jerky carotid pulse, an ejection systolic murmur is audible at the base of the heart which enhances on standing and Valsalva and a pan systolic murmur at the apex. Echocardiography shows asymmetric left ventricular hypertrophy and systolic anterior motion of the mitral valve. The patient's symptoms may be treated with:</span></p>",
      "unique_key": "DT1190615",
      "question_audio": null,
      "question_video": null,
      "map_id": 1190615,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<ul>\r\n<li><strong>Metoprolol is correct</strong> because it is a <strong>beta-blocker</strong>, the <strong>first-line treatment</strong> for symptomatic hypertrophic obstructive cardiomyopathy (HCM)</li>\r\n<li>It <strong>reduces myocardial contractility</strong>, <strong>slows heart rate</strong>, and <strong>prolongs diastolic filling time</strong>, relieving symptoms like <strong>dyspnoea</strong> and <strong>palpitations</strong></li>\r\n<li>These effects <strong>decrease left ventricular outflow tract obstruction</strong>, the main cause of symptoms in HCM</li>\r\n<li>The patient's signs-<strong>jerky carotid pulse</strong>, <strong>ejection systolic murmur increasing with standing and Valsalva</strong>, and <strong>asymmetric LV hypertrophy with systolic anterior motion of the mitral valve</strong> on echo-are classic for HCM</li>\r\n<li>Other findings may include <strong>double apical impulse</strong> and <strong>pulsus bisferiens</strong></li>\r\n<li>HCM carries a risk of <strong>sudden cardiac death</strong>, especially in young individuals due to <strong>ventricular arrhythmias (VT/VF)</strong></li>\r\n<li><strong>First-line medications</strong> include <strong>beta-blockers</strong> and <strong>non-dihydropyridine calcium channel blockers</strong> like <strong>verapamil</strong></li>\r\n<li><strong>Disopyramide</strong> is used as <strong>second-line therapy</strong> for persistent symptoms despite first-line treatment</li>\r\n</ul>\r\n<p><strong>Explanation of Other Options:</strong></p>\r\n<p><strong>Ramipril (Option A):</strong> Ramipril is an <strong>ACE inhibitor</strong>. These agents primarily cause <strong>vasodilation</strong>, which can <strong>reduce afterload and preload</strong>. In HCM, this effect <strong>may exacerbate left ventricular outflow tract obstruction</strong> by increasing the dynamic obstruction.</p>\r\n<p><strong>Frusemide (Option B):</strong> Frusemide is a <strong>loop diuretic</strong>. Diuretics work by <strong>reducing preload</strong>. In HCM, a <strong>reduction in preload can worsen the outflow tract obstruction</strong> and compromise cardiac output due to impaired diastolic filling.</p>\r\n<p><strong>Aspirin (Option C):</strong> Aspirin is an <strong>antiplatelet agent</strong>. Its primary role involves <strong>antithrombotic effects</strong> useful in conditions like ischemic heart disease. Aspirin <strong>does not directly address the pathophysiology of HCM</strong> or its associated symptoms like dyspnoea and palpitations related to outflow tract obstruction.</p>\r\n<p><strong>Key Takeaway:</strong></p>\r\n<p>Beta-blockers are the cornerstone of medical management for symptomatic hypertrophic obstructive cardiomyopathy (HCM) to improve symptoms by reducing outflow tract obstruction. Medications that decrease preload or afterload should generally be avoided in HCM.</p>",
      "correct_choice_id": 4,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 2,
      "choices": [
        {
          "id": 11,
          "text": "<p><span style=\"font-size:12.0pt;\">Constrictive pericarditis</span></p>"
        },
        {
          "id": 12,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypertrophic Cardiomyopathy</span></p>"
        },
        {
          "id": 13,
          "text": "<p><span style=\"font-size:12.0pt;\">Dilated cardiomyopathy</span></p>"
        },
        {
          "id": 14,
          "text": "<p><span style=\"font-size:12.0pt;\">Restrictive cardiomyopathy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 22-year-old student presents with a history of breathlessness on exertion and orthopnoea, fatigue and anorexia. On examination he has peripheral oedema, ascites, hepatomegaly, a low volume pulse, elevated JVP with a rapid y descent, no inspiratory increase in JVP, and S4 was heard on auscultation. ECG shows a low voltage QRS complex with diffuse nonspecific repolarization changes. What is the likely diagnosis? </span></p>",
      "unique_key": "DT1190616",
      "question_audio": null,
      "question_video": null,
      "map_id": 1190616,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<ul>\r\n<li>The patient presents with a constellation of symptoms and signs highly indicative of <strong>Restrictive Cardiomyopathy (RCM)</strong>. Key findings include both <strong>right-sided heart failure features</strong> (peripheral oedema, ascites, hepatomegaly, elevated JVP with rapid y descent) and <strong>left-sided heart failure features</strong> (breathlessness on exertion, orthopnoea, low volume pulse).</li>\r\n<li>The presence of an <strong>S4 heart sound</strong> is a crucial diagnostic clue, as it reflects increased atrial contraction attempting to fill a non-compliant ventricle, a hallmark of RCM. An S4 is <strong>classically seen in restrictive cardiomyopathy</strong> and is almost never heard in constrictive pericarditis.</li>\r\n<li>The <strong>low voltage QRS complex with diffuse nonspecific repolarization changes on ECG</strong> are also commonly associated with RCM, particularly in etiologies like amyloidosis.</li>\r\n</ul>\r\n<p><strong>Explanation of Other Options:</strong></p>\r\n<p><strong>Constrictive pericarditis (Option A):</strong> This condition presents with predominant right-sided heart failure, an elevated JVP with a rapid y descent, and can have a low voltage ECG. Classical features include a <strong>prominent X descent</strong> in JVP, a <strong>positive Kussmaul sign (inspiratory increase in JVP)</strong>, and sometimes a pericardial knock on auscultation, often accompanied by pericardial calcification on imaging.</p>\r\n<p><strong>Hypertrophic Cardiomyopathy (Option B):</strong> Hypertrophic cardiomyopathy is characterized by <strong>asymmetric left ventricular hypertrophy</strong> and often dynamic left ventricular outflow tract obstruction. Patients typically present with dyspnoea, chest pain, and syncope. Characteristic findings include a jerky carotid pulse and an ejection systolic murmur that enhances with maneuvers reducing preload.</p>\r\n<p><strong>Dilated cardiomyopathy (Option C):</strong> Dilated cardiomyopathy involves <strong>dilatation and impaired systolic function of one or both ventricles</strong>, leading to symptoms of biventricular heart failure. Common findings include reduced ejection fraction and signs of volume overload due to pump failure, such as a low cardiac output state.</p>\r\n<p><strong>Key Takeaway:</strong></p>\r\n<p>Restrictive cardiomyopathy is characterized by impaired ventricular filling due to stiff myocardium, often presenting with predominant right-sided heart failure, an elevated JVP with rapid y descent but typically <strong>no Kussmaul sign</strong>, and the classic presence of an <strong>S4 heart sound</strong>. These features are crucial for differentiating it from constrictive pericarditis and other cardiomyopathies.</p>",
      "correct_choice_id": 14,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3,
      "choices": [
        {
          "id": 21,
          "text": "<p><span style=\"font-size:12.0pt;\">LV wall thickness</span></p>"
        },
        {
          "id": 22,
          "text": "<p><span style=\"font-size:12.0pt;\">Systolic anterior motion of the mitral valve</span></p>"
        },
        {
          "id": 23,
          "text": "<p><span style=\"font-size:12.0pt;\">Severity of mitral regurgitation</span></p>"
        },
        {
          "id": 24,
          "text": "<p><span style=\"font-size:12.0pt;\">Gradient across left ventricular outflow tract </span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 25-year-old man whose brother had hypertrophic cardiomyopathy (HCM) was referred for a cardiological assessment. His echocardiogram confirmed the condition. Which one of the following echocardiographic features is the most important risk factor for sudden cardiac death in a patient with HCM? </span></p>",
      "unique_key": "DT1190617",
      "question_audio": null,
      "question_video": null,
      "map_id": 1190617,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<ul>\r\n<li><strong>Increased left ventricular (LV) wall thickness</strong> is identified as the <strong>most important echocardiographic risk factor for sudden cardiac death (SCD)</strong> in patients with Hypertrophic Cardiomyopathy (HCM). A measurement <strong>greater than 3 cm (or &gt; 30 mm)</strong> is considered a major risk factor.</li>\r\n<li>The five poor prognostic markers which are predictive of sudden cardiac death are:\r\n<ol>\r\n<li>Syncope</li>\r\n<li>Family History of HCM and sudden cardiac death</li>\r\n<li>Maximum Left Ventricular Wall Thickness &gt;3cm</li>\r\n<li>BP drop during peak exercise on stress testing</li>\r\n<li>History of cardiac arrest / sustained VT</li>\r\n</ol>\r\n</li>\r\n</ul>\r\n<p><strong>Explanation of Other Options:</strong></p>\r\n<p><strong>Systolic anterior motion of the mitral valve (Option B):</strong> This is a <strong>characteristic echocardiographic finding in HCM</strong> that contributes to left ventricular outflow tract obstruction and can lead to mitral regurgitation. While important for diagnosis and contributing to symptoms, it is <strong>not considered the most important independent echocardiographic risk factor for sudden cardiac death</strong> compared to LV wall thickness.</p>\r\n<p><strong>Severity of mitral regurgitation (Option C):</strong> Mitral regurgitation is a <strong>common consequence of systolic anterior motion of the mitral valve</strong> in HCM, resulting from the distortion of the mitral valve apparatus. While severe mitral regurgitation can contribute to symptoms and heart failure progression, its <strong>severity is not listed as a primary or most important echocardiographic risk factor for sudden cardiac death in HCM</strong>.</p>\r\n<p><strong>Gradient across left ventricular outflow tract (Option D):</strong> An elevated <strong>gradient across the left ventricular outflow tract (LVOT)</strong> signifies the degree of obstruction and often correlates with symptoms. A resting LVOT gradient <strong>greater than 30 mmHg is considered a minor risk factor for sudden cardiac death</strong> in HCM. However, <strong>LV wall thickness is considered a more significant and independent predictor of SCD risk</strong> than the gradient.</p>\r\n<p><strong>Key Takeaway:</strong> In hypertrophic cardiomyopathy (HCM), the <strong>most significant echocardiographic risk factor for sudden cardiac death (SCD) is severe left ventricular wall thickness (especially &gt; 30 mm)</strong>. While other factors like LVOT gradient, syncope, and family history are important, extreme LV hypertrophy carries the highest echocardiographic risk.</p>",
      "correct_choice_id": 21,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4,
      "choices": [
        {
          "id": 31,
          "text": "<p><span style=\"font-size:12.0pt;\">Stress induced cardiomyopathy</span></p>"
        },
        {
          "id": 32,
          "text": "<p><span style=\"font-size:12.0pt;\">Dilated cardiomyopathy following long standing alcohol intake</span></p>"
        },
        {
          "id": 33,
          "text": "<p><span style=\"font-size:12.0pt;\">Atrial fibrillation after binge alcohol consumption</span></p>"
        },
        {
          "id": 34,
          "text": "<p><span style=\"font-size:12.0pt;\">Alcohol induced ventricular tachycardia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following best describes 'Holiday heart syndrome'? </span></p>",
      "unique_key": "DT1190618",
      "question_audio": null,
      "question_video": null,
      "map_id": 1190618,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<ul>\r\n<li><strong>Holiday heart syndrome</strong> is specifically defined as <strong>an acute cardiac rhythm and/or conduction disturbance associated with heavy ethanol consumption</strong> in an individual without other pre-existing clinical evidence of heart disease.</li>\r\n<li>The <strong>most common arrhythmia encountered in this condition is atrial fibrillation</strong>, although other arrhythmias can also occur.</li>\r\n<li>This syndrome typically arises after a period of heavy drinking, often seen during holidays or weekends, hence the name.</li>\r\n</ul>\r\n<p><strong>Explanation of Other Options:</strong></p>\r\n<p><strong>Stress induced cardiomyopathy (Option A):</strong> This condition, also known as Takotsubo cardiomyopathy or broken heart syndrome, is characterized by <strong>transient left ventricular dysfunction</strong> typically brought on by severe emotional or physical stress. Its etiology and presentation are distinct from alcohol consumption.</p>\r\n<p><strong>Dilated cardiomyopathy following long standing alcohol intake (Option B):</strong> This describes <strong>alcoholic cardiomyopathy</strong>, a form of dilated cardiomyopathy resulting from chronic, heavy alcohol consumption. It represents a <strong>structural heart disease</strong> that develops over time due to alcohol's toxic effects, rather than an acute, transient rhythm disturbance like holiday heart syndrome.</p>\r\n<p><strong>Alcohol induced ventricular tachycardia (Option D):</strong> While <strong>ventricular tachycardia (VT) can occur in the context of alcohol consumption</strong>, particularly in established alcoholic cardiomyopathy, \"Holiday heart syndrome\" specifically refers to the <strong>acute onset of <em>any</em> rhythm disturbance, with atrial fibrillation being the most common presentation</strong>. It is a broader term encompassing various arrhythmias linked to binge drinking, not solely VT.</p>\r\n<p><strong>Key Takeaway:</strong> 'Holiday heart syndrome' specifically describes the <strong>acute onset of cardiac rhythm disturbances, most commonly atrial fibrillation</strong>, in individuals without underlying heart disease, following episodes of <strong>heavy alcohol consumption (binge drinking)</strong>. It is distinct from chronic alcoholic cardiomyopathy.</p>",
      "correct_choice_id": 33,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5,
      "choices": [
        {
          "id": 41,
          "text": "<p><span style=\"font-size:12.0pt;\">Mitochondrial inheritance</span></p>"
        },
        {
          "id": 42,
          "text": "<p><span style=\"font-size:12.0pt;\">X-linked dominant</span></p>"
        },
        {
          "id": 43,
          "text": "<p><span style=\"font-size:12.0pt;\">Autosomal recessive</span></p>"
        },
        {
          "id": 44,
          "text": "<p><span style=\"font-size:12.0pt;\">Autosomal dominant</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 28 year old man presents with a history of syncope related to exercise. There is a family history of sudden cardiac death. On examination, the carotid pulse is jerky, there is a double apical pulsation. On auscultation there is a fourth heart sound, an ejection systolic murmur heard at the base of the heart. The inheritance of this condition is most likely: </span></p>",
      "unique_key": "DT1190620",
      "question_audio": null,
      "question_video": null,
      "map_id": 1190620,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<ul>\r\n<li>The clinical presentation of a 28-year-old man with <strong>syncope related to exercise</strong>, a <strong>family history of sudden cardiac death</strong>, a <strong>jerky carotid pulse</strong>, <strong>double apical pulsation</strong>, <strong>fourth heart sound (S4)</strong>, and an <strong>ejection systolic murmur at the base of the heart</strong> is highly suggestive of <strong>Hypertrophic Cardiomyopathy (HCM)</strong>.</li>\r\n<li><strong>Hypertrophic Cardiomyopathy (HCM) is most commonly inherited in an Autosomal Dominant pattern</strong>. This means that only one copy of the altered gene in each cell is sufficient to cause the disorder. It affects approximately 1 in 500 to 1 in 1000 people in the general population.</li>\r\n<li>The genetic mutations associated with HCM primarily affect genes encoding <strong>sarcomeric proteins</strong>, which are essential components of heart muscle cells.</li>\r\n</ul>\r\n<p><strong>Explanation of Other Options:</strong></p>\r\n<p><strong>Mitochondrial inheritance (Option A):</strong> Mitochondrial inheritance involves genes located in the <strong>mitochondrial DNA</strong>, which are inherited exclusively from the mother. While some cardiac conditions, such as <strong>Kearns-Sayre syndrome (conduction defects)</strong>, exhibit mitochondrial inheritance, HCM's primary mode of inheritance is not mitochondrial.</p>\r\n<p><strong>X-linked dominant (Option B):</strong> X-linked dominant disorders are caused by mutations on the X chromosome, where one copy of the altered gene in each cell is sufficient to cause the disorder. Affected males typically have more severe symptoms than affected females. While there are X-linked cardiac conditions (e.g., Fabry disease can cause restrictive cardiomyopathy, X-linked recessive), <strong>HCM is not typically inherited in an X-linked dominant pattern</strong>.</p>\r\n<p><strong>Autosomal recessive (Option C):</strong> Autosomal recessive disorders occur when an individual inherits two copies of an altered gene, one from each parent. While some inherited cardiac diseases, such as <strong>Friedreich's ataxia (which can present with hypertrophic cardiomyopathy)</strong>, are autosomal recessive, this is <strong>not the most common or characteristic inheritance pattern for isolated HCM</strong>. Other conditions like Duchenne muscular dystrophy (X-linked recessive with dilated cardiomyopathy) and Fabry disease (X-linked recessive with restrictive cardiomyopathy) also have different inheritance patterns.</p>\r\n<p><strong>Key Takeaway:</strong> Hypertrophic Cardiomyopathy (HCM), a common cause of exercise-induced syncope and sudden cardiac death in young individuals, is predominantly inherited in an <strong>Autosomal Dominant fashion</strong>, often due to mutations in sarcomeric protein genes.</p>",
      "correct_choice_id": 44,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6,
      "choices": [
        {
          "id": 51,
          "text": "<p><span style=\"font-size:12.0pt;\">Hand grip accentuates the murmur in HCM</span></p>"
        },
        {
          "id": 52,
          "text": "<p><span style=\"font-size:12.0pt;\">Dynamic LVOT obstruction is a typical feature</span></p>"
        },
        {
          "id": 53,
          "text": "<p><span style=\"font-size:12.0pt;\">Beta blockers are the preferred agents in medical management</span></p>"
        },
        {
          "id": 54,
          "text": "<p><span style=\"font-size:12.0pt;\">ECG shows LVH with prominent Q waves</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is not true regarding hypertrophic cardiomyopathy (HCM)? </span></p>",
      "unique_key": "DT1190622",
      "question_audio": null,
      "question_video": null,
      "map_id": 1190622,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<ul>\r\n<li>The statement \"Hand grip accentuates the murmur in HCM\" is <strong>not true</strong>. Handgrip maneuver <strong>increases afterload</strong>, which leads to <strong>reduced intensity of the murmur in HCM</strong>. This is because increased afterload helps to distend the left ventricle, thereby reducing the outflow tract obstruction. Conversely, maneuvers that decrease preload or afterload (like Valsalva or standing) increase the murmur intensity in HCM.</li>\r\n<li><strong>Dynamic left ventricular outflow tract (LVOT) obstruction is a typical and hallmark feature of HCM</strong> (Option B). This obstruction is primarily caused by systolic anterior motion (SAM) of the mitral leaflet and asymmetric septal hypertrophy.</li>\r\n<li><strong>Beta-blockers are indeed the preferred agents in medical management for HCM</strong> (Option C). They work by reducing myocardial contractility, decreasing heart rate, and prolonging diastolic filling time, which helps to alleviate the LVOT obstruction and improve symptoms. Non-dihydropyridine calcium channel blockers (like verapamil) are also preferred.</li>\r\n<li><strong>ECG findings in HCM commonly show left ventricular hypertrophy (LVH) with strain pattern and prominent Q waves</strong> (Option D). The prominent Q waves, particularly in inferior and lateral leads, can mimic myocardial infarction but represent septal hypertrophy.</li>\r\n</ul>\r\n<p><strong>Explanation of Other Options:</strong></p>\r\n<p><strong>Dynamic LVOT obstruction is a typical feature (Option B):</strong> This statement is <strong>true</strong>. Dynamic LVOT obstruction is a <strong>hallmark pathological and physiological feature of HCM</strong>, caused by the interplay of asymmetric septal hypertrophy and systolic anterior motion of the mitral valve.</p>\r\n<p><strong>Beta blockers are the preferred agents in medical management (Option C):</strong> This statement is <strong>true</strong>. <strong>Beta-blockers are cornerstone medications for symptomatic HCM</strong>, effectively managing symptoms by reducing myocardial contractility and relieving outflow tract obstruction.</p>\r\n<p><strong>ECG shows LVH with prominent Q waves (Option D):</strong> This statement is <strong>true</strong>. The ECG in HCM frequently demonstrates <strong>evidence of left ventricular hypertrophy (LVH)</strong>. Additionally, <strong>prominent Q waves, particularly in the inferolateral leads</strong>, are a characteristic finding, reflecting the abnormal septal depolarization due to hypertrophy.</p>\r\n<p><strong>Key Takeaway:</strong> Unlike most murmurs, the <strong>murmur of Hypertrophic Cardiomyopathy (HCM) <em>decreases</em> with maneuvers that increase afterload (like handgrip) and <em>increases</em> with maneuvers that decrease preload or afterload (like Valsalva or standing)</strong>. This paradoxical response is a key diagnostic differentiator for HCM.</p>",
      "correct_choice_id": 51,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7,
      "choices": [
        {
          "id": 61,
          "text": "<p><span style=\"font-size:12.0pt;\">Spironolactone</span></p>"
        },
        {
          "id": 62,
          "text": "<p><span style=\"font-size:12.0pt;\">Isosorbide dinitrate</span></p>"
        },
        {
          "id": 63,
          "text": "<p><span style=\"font-size:12.0pt;\">Digoxin</span></p>"
        },
        {
          "id": 64,
          "text": "<p><span style=\"font-size:12.0pt;\">Amiodarone</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 65 year old lady, diagnosed with ischaemic cardiomyopathy has breathlessness walking up one flight of stairs. Her lung fields are clear. Chest X ray shows cardiomegaly and clear lung fields. She is currently on frusemide 40mg bd, ramipril 5 mg and Metoprolol 100 mg per day. Which of the following medications would be the most appropriate addition? </span></p>",
      "unique_key": "DT1190624",
      "question_audio": null,
      "question_video": null,
      "map_id": 1190624,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<ul>\r\n<li>The patient has <strong>ischemic cardiomyopathy</strong> and presents with symptoms of heart failure (breathlessness on exertion) despite being on a loop diuretic (Frusemide), an ACE inhibitor (Ramipril), and a beta-blocker (Metoprolol). This suggests she has <strong>Heart Failure with reduced Ejection Fraction (HFrEF)</strong>, as these are foundational therapies for this condition.</li>\r\n<li>The most appropriate addition to her current regimen, based on evidence for <strong>mortality benefit in HFrEF</strong>, would be <strong>Spironolactone (Option A)</strong>. Spironolactone is a <strong>mineralocorticoid receptor antagonist (MRA)</strong>, a class of drugs that has been shown to significantly improve outcomes and reduce mortality in patients with HFrEF when added to ACE inhibitors/ARBs and beta-blockers.</li>\r\n<li>The current guidelines for HFrEF management recommend a quad therapy approach including an ACE inhibitor/ARB/ARNI, a beta-blocker, an MRA, and an SGLT2 inhibitor for patients who remain symptomatic.</li>\r\n</ul>\r\n<p><strong>Explanation of Other Options:</strong></p>\r\n<p><strong>Isosorbide dinitrate (Option B):</strong> Isosorbide dinitrate is a <strong>nitrate</strong>, primarily used as a vasodilator to reduce preload and provide symptomatic relief, especially for angina. While nitrates can be part of a regimen (e.g., in African American patients with HFrEF in combination with hydralazine, or for symptomatic angina), they <strong>do not confer a mortality benefit in the broad HFrEF population</strong> as a standalone addition like MRAs.</p>\r\n<p><strong>Digoxin (Option C):</strong> Digoxin is a <strong>cardiac glycoside</strong> that has positive inotropic effects and negative chronotropic effects. It is primarily used for <strong>symptomatic relief and to reduce hospitalizations in HFrEF patients with persistent symptoms</strong>, particularly those with atrial fibrillation with rapid ventricular response. However, <strong>digoxin does not have a proven mortality benefit in HFrEF</strong> and its use is typically considered after foundational therapies are optimized.</p>\r\n<p><strong>Amiodarone (Option D):</strong> Amiodarone is a <strong>Class III antiarrhythmic drug</strong>. It is used to <strong>treat and prevent various cardiac arrhythmias</strong>, including atrial fibrillation and ventricular arrhythmias. While arrhythmias can complicate heart failure, <strong>Amiodarone's primary role is rhythm control, not improvement in heart failure mortality</strong> in the absence of specific indications for arrhythmia management. It also carries significant side effects.</p>\r\n<p><strong>Key Takeaway:</strong> In patients with Heart Failure with reduced Ejection Fraction (HFrEF) who are already on an ACE inhibitor/ARB and a beta-blocker, the addition of a <strong>mineralocorticoid receptor antagonist (MRA) such as Spironolactone</strong> is crucial for <strong>improving mortality outcomes</strong> based on current evidence-based guidelines.</p>",
      "correct_choice_id": 61,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8,
      "choices": [
        {
          "id": 71,
          "text": "<p><span style=\"font-size:12.0pt;\">Transthoracic echocardiogram</span></p>"
        },
        {
          "id": 72,
          "text": "<p><span style=\"font-size:12.0pt;\">Transoesophageal echocardiogram</span></p>"
        },
        {
          "id": 73,
          "text": "<p><span style=\"font-size:12.0pt;\">Electrophysiological study</span></p>"
        },
        {
          "id": 74,
          "text": "<p><span style=\"font-size:12.0pt;\">Holter study</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 40-year-old man presented to your clinic because he is concerned about his family history of hypertrophic obstructive cardiomyopathy. His brother has recently died due to the condition. Which is the preferred investigation for screening for HCM in the patient? </span></p>",
      "unique_key": "DT1190625",
      "question_audio": null,
      "question_video": null,
      "map_id": 1190625,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<ul>\r\n<li><strong>Transthoracic echocardiogram (TTE)</strong> is the <strong>preferred and initial screening modality for hypertrophic obstructive cardiomyopathy (HCM)</strong> in patients, especially those with a family history of the condition, particularly in the context of a sudden cardiac death.</li>\r\n<li>TTE provides a <strong>non-invasive and comprehensive assessment of cardiac structure and function</strong>, including evaluation of left ventricular hypertrophy, outflow tract obstruction, and mitral valve motion, which are key features of HCM.</li>\r\n<li>Relatives of patients diagnosed with HCM, particularly after a fatality within the family, should be offered screening to identify early signs of the condition and guide management.</li>\r\n<li><strong>Cardiac MRI</strong> may also be performed as a <strong>second-line investigation</strong> or for more detailed assessment, especially in complex cases or during follow-up after interventions like surgical myomectomy or septal ablation therapy.</li>\r\n</ul>\r\n<p><strong>Explanation of Other Options:</strong></p>\r\n<p><strong>Transoesophageal echocardiogram (Option B):</strong> Transoesophageal echocardiogram (TOE) provides <strong>more detailed images of cardiac structures</strong> compared to TTE, particularly for posterior structures or in cases where TTE images are suboptimal. However, TOE is a <strong>semi-invasive procedure</strong> and is <strong>not considered the preferred initial screening modality</strong> for HCM due to its invasive nature. Its use is reserved for specific indications such as guiding interventions or evaluating complex mitral valve pathology.</p>\r\n<p><strong>Electrophysiological study (Option C):</strong> An electrophysiological (EP) study is an <strong>invasive procedure used to evaluate the heart's electrical activity</strong> and identify the cause of arrhythmias, or to guide ablation procedures. While HCM patients are at risk for arrhythmias, an EP study is <strong>not a primary screening tool for the structural diagnosis of HCM</strong>. It is typically reserved for risk stratification or management of specific arrhythmias in diagnosed HCM patients.</p>\r\n<p><strong>Holter study (Option D):</strong> A Holter study (ambulatory ECG monitoring) is a <strong>non-invasive test used to record the heart's electrical activity continuously over a period (usually 24-48 hours)</strong> to detect transient arrhythmias. While a Holter study is crucial for <strong>identifying arrhythmias (like non-sustained ventricular tachycardia)</strong> that contribute to sudden cardiac death risk in HCM, it <strong>does not provide structural information about the heart muscle</strong> itself and is therefore <strong>not a screening tool for the diagnosis of HCM</strong>.</p>\r\n<p><strong>Key Takeaway:</strong></p>\r\n<p><strong>Transthoracic echocardiogram (TTE) is the cornerstone and preferred initial non-invasive investigation for screening and diagnosing hypertrophic cardiomyopathy (HCM)</strong>, especially in at-risk individuals with a family history of the condition.</p>",
      "correct_choice_id": 71,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9,
      "choices": [
        {
          "id": 81,
          "text": "<p><span style=\"font-size:12.0pt;\">Anti-centromere antibody titer of 1:320</span></p>"
        },
        {
          "id": 82,
          "text": "<p><span style=\"font-size:12.0pt;\">Erythrocyte sedimentation rate of 79 mm/Hr</span></p>"
        },
        {
          "id": 83,
          "text": "<p><span style=\"font-size:12.0pt;\">Amyloid deposits on tissue biopsy</span></p>"
        },
        {
          "id": 84,
          "text": "<p><span style=\"font-size:12.0pt;\">Serum ferritin of 2160 ng/ml </span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 44-year-old man has had no major medical problems throughout his life, except for arthritis involving both small and large joints for the past couple of years. He has had worsening orthopnea and ankle oedema in the past six months. He is afebrile. There is no chest pain. Chest X-ray shows cardiomegaly with features of pulmonary oedema. Laboratory test findings include sodium 139 mmol/L, potassium 4.3 mmol/L, urea 28 mg/dl creatinine 0.90 mg/dL, and fasting plasma glucose of 255 mg/dl. Which of the following additional laboratory test findings is he most likely to have? </span></p>",
      "unique_key": "DT1190629",
      "question_audio": null,
      "question_video": null,
      "map_id": 1190629,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<ul>\r\n<li>The patient presents with symptoms and signs of <strong>biventricular heart failure</strong> (orthopnoea, ankle oedema, cardiomegaly, pulmonary oedema). The history of <strong>arthritis involving both small and large joints</strong> and new-onset <strong>diabetes mellitus</strong> (fasting plasma glucose of 255 mg/dL) in a 44-year-old man should raise strong suspicion for a <strong>systemic disorder affecting the heart</strong>.</li>\r\n<li>Given these findings, <strong>hemochromatosis</strong> is a highly likely diagnosis. Hemochromatosis is characterized by <strong>iron overload</strong>, which can lead to a classic triad of <strong>diabetes mellitus, chronic liver disease, and slate-grey skin pigmentation</strong>, along with <strong>arthropathy (arthritis)</strong> and <strong>cardiac involvement, typically restrictive cardiomyopathy</strong>.</li>\r\n<li>A <strong>serum ferritin level greater than 1000 ng/ml</strong> is a key indicator that strongly suggests hereditary hemochromatosis. A value of <strong>2160 ng/ml (Option D)</strong> fits this criterion perfectly, making it the most likely additional laboratory finding. Hereditary hemochromatosis is an autosomal recessive condition, often due to mutations in the HFE gene.</li>\r\n</ul>\r\n<p><strong>Explanation of Other Options:</strong></p>\r\n<p><strong>Anti-centromere antibody titer of 1:320 (Option A):</strong> Anti-centromere antibodies are <strong>highly specific for Limited Cutaneous Systemic Sclerosis (CREST syndrome)</strong>, which can involve the heart (e.g., pulmonary hypertension, pericardial effusion, myocardial fibrosis). While arthritis can be seen, the typical cardiac involvement in hemochromatosis (restrictive cardiomyopathy) and the specific association with diabetes and very high ferritin <strong>do not align with anti-centromere antibodies</strong>.</p>\r\n<p><strong>Erythrocyte sedimentation rate of 79 mm/Hr (Option B):</strong> An Erythrocyte Sedimentation Rate (ESR) of 79 mm/Hr indicates <strong>significant inflammation</strong>. While high ESR can be seen in various inflammatory conditions including some rheumatic diseases (e.g., rheumatoid arthritis) that can have cardiac manifestations, it is a <strong>non-specific marker</strong> and does not specifically point to the underlying diagnosis suggested by the constellation of symptoms, particularly the diabetes and suspicion of iron overload.</p>\r\n<p><strong>Amyloid deposits on tissue biopsy (Option C):</strong> Amyloidosis is a systemic disorder caused by the <strong>abnormal extracellular deposition of insoluble amyloid fibrils</strong>, which can significantly affect the heart, leading to <strong>restrictive cardiomyopathy</strong>. While amyloidosis can present with heart failure, arthropathy (carpal tunnel syndrome, shoulder pad sign), and sometimes diabetes, the <strong>absence of other classic features</strong> (like macroglossia, periorbital purpura) and the <strong>strong pointer towards iron overload with high ferritin</strong> make amyloid deposits less likely as the primary diagnosis compared to hemochromatosis in this specific scenario. Hemochromatosis is directly linked to elevated ferritin.</p>\r\n<p><strong>Key Takeaway:</strong> The combination of <strong>heart failure, arthritis, and diabetes mellitus</strong> in a middle-aged man should strongly prompt consideration of <strong>hereditary hemochromatosis</strong>. A <strong>markedly elevated serum ferritin level (typically &gt; 1000 ng/ml)</strong> is the most crucial laboratory indicator for this iron overload disorder.</p>",
      "correct_choice_id": 84,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10,
      "choices": [
        {
          "id": 91,
          "text": "<p><span style=\"font-size:12.0pt;\">HIV infection</span></p>"
        },
        {
          "id": 92,
          "text": "<p><span style=\"font-size:12.0pt;\">Chagas disease</span></p>"
        },
        {
          "id": 93,
          "text": "<p><span style=\"font-size:12.0pt;\">Diphtheria</span></p>"
        },
        {
          "id": 94,
          "text": "<p><span style=\"font-size:12.0pt;\">Coxsackie virus infection </span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is the most common infective cause of cardiomyopathy? </span></p>",
      "unique_key": "DT1190637",
      "question_audio": null,
      "question_video": null,
      "map_id": 1190637,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<ul>\r\n<li><strong>Chagas disease, caused by the parasite <em>Trypanosoma cruzi</em> and transmitted by the reduviid bug, is widely recognized as the most common infectious cause of cardiomyopathy globally.</strong> It is particularly prevalent in Latin America.</li>\r\n<li>Chagasic cardiomyopathy often leads to <strong>dilated cardiomyopathy</strong>, which can result in significant cardiac dysfunction, arrhythmias (including <strong>AV blocks</strong>), and heart failure.</li>\r\n<li>While other infections can cause cardiomyopathy or myocarditis, Chagas disease holds the distinction for the highest prevalence as an infective cause of chronic cardiomyopathy.</li>\r\n</ul>\r\n<p><strong>Explanation of Other Options:</strong></p>\r\n<p><strong>HIV infection (Option A):</strong> HIV infection can lead to <strong>HIV-associated cardiomyopathy</strong>, typically a dilated cardiomyopathy. This is a significant cause of heart disease in HIV-positive individuals, but it is <strong>not considered the most common infective cause of cardiomyopathy globally</strong> when compared to Chagas disease.</p>\r\n<p><strong>Diphtheria (Option C):</strong> Diphtheria, caused by <em>Corynebacterium diphtheriae</em>, can produce a potent exotoxin that can lead to <strong>myocarditis and cardiomyopathy</strong>, often severe. While a notable cause of cardiac involvement, it is now <strong>rare in vaccinated populations</strong> and is not the most common global infective cause of cardiomyopathy.</p>\r\n<p><strong>Coxsackie virus infection (Option D):</strong> Coxsackie viruses (especially B serotypes) are a <strong>common cause of viral myocarditis</strong>, which can sometimes progress to dilated cardiomyopathy. Along with parvovirus B19 and echoviruses, Coxsackie viruses are among the <strong>most frequent viral causes of myocarditis</strong>. However, when considering <em>all</em> infective causes of <em>cardiomyopathy</em>, <strong>Chagas disease surpasses it in overall prevalence as the leading cause</strong>.</p>\r\n<p><strong>Key Takeaway:</strong> Globally, <strong>Chagas disease</strong>, caused by <em>Trypanosoma cruzi</em>, stands as the <strong>most common infective cause of cardiomyopathy</strong>, often leading to dilated cardiomyopathy with characteristic conduction abnormalities.</p>",
      "correct_choice_id": 92,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11,
      "choices": [
        {
          "id": 101,
          "text": "<p><span style=\"font-size:12.0pt;\">Diltiazem</span></p>"
        },
        {
          "id": 102,
          "text": "<p><span style=\"font-size:12.0pt;\">Digoxin</span></p>"
        },
        {
          "id": 103,
          "text": "<p><span style=\"font-size:12.0pt;\">Isosorbide Mononitrate</span></p>"
        },
        {
          "id": 104,
          "text": "<p><span style=\"font-size:12.0pt;\">Nicorandil</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 65-year-old male attends a clinic complaining of breathlessness and persistent fatigue. He has end stage cardiac failure due to dilated cardiomyopathy. Currently he takes Furosemide, Lisinopril, Spironolactone and Carvedilol. Which one of the following drugs should be added to his current therapy? </span></p>",
      "unique_key": "DT1190638",
      "question_audio": null,
      "question_video": null,
      "map_id": 1190638,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<ul>\r\n<li>The patient has <strong>end-stage cardiac failure due to dilated cardiomyopathy</strong> and is already on <strong>optimal guideline-directed medical therapy for Heart Failure with reduced Ejection Fraction (HFrEF)</strong>, including a loop diuretic (Furosemide), an ACE inhibitor (Lisinopril), a mineralocorticoid receptor antagonist (Spironolactone), and a beta-blocker (Carvedilol). Despite this, he remains symptomatic with breathlessness and persistent fatigue.</li>\r\n<li>In such a scenario, <strong>Digoxin (Option B)</strong> is the most appropriate addition. Digoxin has a <strong>positive inotropic effect</strong> (increases myocardial contractility) and can be used to <strong>improve symptoms and reduce hospitalizations</strong> in patients with HFrEF who remain symptomatic despite optimal background therapy and are in sinus rhythm. It helps to alleviate symptoms and improve quality of life.</li>\r\n</ul>\r\n<p><strong>Explanation of Other Options:</strong></p>\r\n<p><strong>Diltiazem (Option A):</strong> Diltiazem is a <strong>non-dihydropyridine calcium channel blocker</strong> with negative inotropic and chronotropic effects. These agents are generally <strong>contraindicated in HFrEF</strong> as they can further depress myocardial contractility and worsen heart failure. They are primarily used for rate control in atrial fibrillation or for angina, but not in the setting of systolic heart failure.</p>\r\n<p><strong>Isosorbide Mononitrate (Option C):</strong> Isosorbide mononitrate is a <strong>long-acting nitrate</strong> that primarily causes <strong>venodilation</strong>, reducing preload, and to a lesser extent, arterial dilation, reducing afterload. While nitrates are used for symptomatic relief of angina and can be part of heart failure management (e.g., in combination with hydralazine in certain patient populations or for persistent congestion), it <strong>does not offer additional mortality benefit</strong> over the existing foundational HFrEF therapy and is typically not the next preferred symptomatic agent in this context.</p>\r\n<p><strong>Nicorandil (Option D):</strong> Nicorandil is a <strong>potassium channel opener with nitrate-like properties</strong>. It causes both arterial and venous dilation and is primarily used as an <strong>anti-anginal agent</strong>. It is <strong>not a standard medication for the management of chronic heart failure</strong> or proven to reduce morbidity or mortality in patients with HFrEF beyond foundational therapies.</p>\r\n<p><strong>Key Takeaway:</strong> In patients with <strong>end-stage Heart Failure with reduced Ejection Fraction (HFrEF)</strong> who remain symptomatic despite optimal guideline-directed medical therapy (ACEi/ARB, beta-blocker, MRA, diuretic), <strong>Digoxin</strong> can be added to <strong>alleviate symptoms and reduce hospitalizations</strong>, though it does not provide a mortality benefit.</p>",
      "correct_choice_id": 102,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12,
      "choices": [
        {
          "id": 111,
          "text": "<p><span style=\"font-size:12.0pt;\">Functional mitral regurgitation may be seen</span></p>"
        },
        {
          "id": 112,
          "text": "<p><span style=\"font-size:12.0pt;\">Increased atrial size</span></p>"
        },
        {
          "id": 113,
          "text": "<p><span style=\"font-size:12.0pt;\">Ejection fraction is usually preserved till later stages</span></p>"
        },
        {
          "id": 114,
          "text": "<p><span style=\"font-size:12.0pt;\">Left sided failure occurs earlier than right sided heart failure </span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is not true regarding dilated cardiomyopathy? </span></p>",
      "unique_key": "DT1190640",
      "question_audio": null,
      "question_video": null,
      "map_id": 1190640,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<ul>\r\n<li>The statement \"<strong>Ejection fraction is usually preserved till later stages</strong>\" (Option C) is <strong>not true</strong> regarding dilated cardiomyopathy (DCM). Dilated cardiomyopathy is fundamentally characterized by <strong>systolic dysfunction</strong>, meaning the heart's ability to pump blood effectively is impaired from relatively early symptomatic stages. The <strong>ejection fraction (EF) is typically significantly reduced (often &lt;40%, and commonly &lt;30%)</strong> when patients develop noticeable symptoms, indicating impaired pumping function.</li>\r\n<li>Functional mitral regurgitation may be seen <strong>(Option A)</strong>. Due to the <strong>dilation of the left ventricle and mitral annulus</strong>, the mitral valve leaflets may no longer coapt properly, leading to <strong>functional (or secondary) mitral regurgitation</strong>.</li>\r\n<li>Increased atrial size<strong> (Option B)</strong>. The dilation of the ventricles often leads to <strong>increased pressure within the atria</strong>, causing them to <strong>enlarge</strong> as they try to accommodate the increased volume and pressure.</li>\r\n<li>Left sided failure occurs earlier than right sided heart failure <strong>(Option D)</strong>. In DCM, the <strong>left ventricle is typically affected first and more severely</strong>, leading to symptoms of left-sided heart failure such as <strong>dyspnoea, orthopnoea, and paroxysmal nocturnal dyspnoea</strong>. Right-sided heart failure symptoms (e.g., peripheral oedema, hepatomegaly) often develop later as the disease progresses and affects the right ventricle.</li>\r\n</ul>\r\n<p><strong>Key Takeaway:</strong> Dilated cardiomyopathy is primarily characterized by <strong>systolic dysfunction and a significantly reduced ejection fraction</strong> even in relatively early symptomatic stages, not preservation of ejection fraction until later. Key features include ventricular dilation, functional mitral regurgitation, and often earlier onset of left-sided heart failure symptoms.</p>",
      "correct_choice_id": 113,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13,
      "choices": [
        {
          "id": 121,
          "text": "<p><span style=\"font-size:12.0pt;\">Complete heart block</span></p>"
        },
        {
          "id": 122,
          "text": "<p><span style=\"font-size:12.0pt;\">Atrial fibrillation</span></p>"
        },
        {
          "id": 123,
          "text": "<p><span style=\"font-size:12.0pt;\">Atrial flutter</span></p>"
        },
        {
          "id": 124,
          "text": "<p><span style=\"font-size:12.0pt;\">Ventricular tachycardia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is the most common arrhythmia in patients with restrictive cardiomyopathy (RCM)? </span></p>",
      "unique_key": "DT1190643",
      "question_audio": null,
      "question_video": null,
      "map_id": 1190643,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<ul>\r\n<li><strong>Atrial fibrillation </strong>is the <strong>most common arrhythmia observed in patients with restrictive cardiomyopathy (RCM)</strong>. This is due to the characteristic <strong>increased atrial pressure and dilation</strong> that results from the stiff, non-compliant ventricles typical of RCM, which creates a substrate for re-entrant circuits in the atria.</li>\r\n<li>The impaired ventricular filling in RCM leads to elevated atrial pressures and subsequent atrial enlargement, predisposing to various atrial arrhythmias, with atrial fibrillation being the most prevalent. Higher degrees of heart block can also occur, but atrial fibrillation is more common.</li>\r\n</ul>\r\n<p><strong>Explanation of Other Options:</strong></p>\r\n<p><strong>Complete heart block (Option A):</strong> Complete heart block (third-degree AV block) involves a <strong>complete dissociation between atrial and ventricular activity</strong>. While conduction abnormalities, including higher degrees of heart block, can occur in RCM (especially in specific etiologies like cardiac amyloidosis), <strong>atrial fibrillation is more frequently encountered</strong> as the primary arrhythmia.</p>\r\n<p><strong>Atrial flutter (Option C):</strong> Atrial flutter is an <strong>organized atrial arrhythmia</strong> characterized by rapid, regular atrial activity, often resulting from a re-entrant circuit within the right atrium. While atrial flutter can occur in patients with underlying heart disease, including RCM, <strong>atrial fibrillation is significantly more common</strong> due to the more chaotic and multifocal re-entry pathways often seen with extensive atrial remodeling in RCM.</p>\r\n<p><strong>Ventricular tachycardia (Option D):</strong> Ventricular tachycardia (VT) is a <strong>rapid heart rhythm originating from the ventricles</strong>. VT is <strong>most commonly associated with hypertrophic cardiomyopathy (HCM)</strong> and ischemic heart disease, where structural abnormalities or scar tissue provide a substrate for ventricular re-entry. While serious ventricular arrhythmias can occur in advanced RCM, <strong>atrial fibrillation remains the most prevalent arrhythmia in RCM patients</strong>.</p>\r\n<p><strong>Key Takeaway:</strong> <strong>Atrial fibrillation is the most common arrhythmia in patients with restrictive cardiomyopathy (RCM)</strong>, primarily due to the chronically elevated atrial pressures and subsequent atrial dilation caused by the non-compliant ventricles.</p>",
      "correct_choice_id": 122,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14,
      "choices": [
        {
          "id": 131,
          "text": "<p><span style=\"font-size:12.0pt;\">Positive anti-nuclear antibodies</span></p>"
        },
        {
          "id": 132,
          "text": "<p><span style=\"font-size:12.0pt;\">Antistreptolysin O titer of 1:512</span></p>"
        },
        {
          "id": 133,
          "text": "<p><span style=\"font-size:12.0pt;\">Blood culture positive for Streptococcus, viridans group</span></p>"
        },
        {
          "id": 134,
          "text": "<p><span style=\"font-size:12.0pt;\">Coxsackie B serologic titer of 1:160</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 25-year-old previously healthy woman has worsening fatigue with dyspnoea, palpitations, and fever over the past one week. Her clinical examination showed temperature 38.9C, respiratory rate 30/min, pulse rate of 105 bpm and BP of 95/65 mmHg. An ECG showed diffuse ST-T segment changes. Echocardiogram showed slight mitral and tricuspid regurgitation, global left ventricular hypokinesia, but no valvular vegetations. Her troponin I was 12 ng/mL (NR<0.04). She recovers over the next two weeks with no apparent sequelae. Which of the following laboratory test findings best explains the underlying etiology for these events? </span></p>",
      "unique_key": "DT1190645",
      "question_audio": null,
      "question_video": null,
      "map_id": 1190645,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<ul>\r\n<li>The patient presents with <strong>acute onset of fever, symptoms of cardiac dysfunction (dyspnoea, palpitations, fatigue, hypotension, tachycardia)</strong>, diffuse ST-T changes on ECG, global left ventricular hypokinesia on echocardiogram, and a <strong>markedly elevated troponin I level (12 ng/mL)</strong>. These findings are highly characteristic of <strong>acute myocarditis</strong>. The rapid recovery within two weeks without apparent sequelae further supports an acute inflammatory process, typical of viral etiology.</li>\r\n<li><strong>Viruses are the most common cause of myocarditis</strong>, and <strong>Coxsackie virus (especially B serotypes) is a leading cause</strong> among them, along with parvovirus B19 and adenoviruses. A <strong>Coxsackie B serologic titer of 1:160 (Option D)</strong> indicates recent or active infection with the Coxsackie B virus, making it the best explanation for the underlying etiology in this clinical scenario.</li>\r\n</ul>\r\n<p><strong>Explanation of Other Options:</strong></p>\r\n<p><strong>Positive anti-nuclear antibodies (Option A):</strong> Positive ANA is associated with <strong>systemic autoimmune diseases</strong>, which can cause myocarditis, but the acute self-limiting nature points to a viral etiology here.</p>\r\n<p><strong>Antistreptolysin O titer of 1:512 (Option B):</strong> An ASO titer indicates a <strong>recent Group A Streptococcus infection</strong>, which can lead to <strong>rheumatic fever carditis</strong>.</p>\r\n<p><strong>Blood culture positive for Streptococcus, viridans group (Option C):</strong> A positive blood culture for <em>Streptococcus, viridans group</em>, strongly suggests <strong>infective endocarditis</strong>, which typically involves <strong>valvular vegetations</strong>.</p>\r\n<p><strong>Key Takeaway:</strong> Acute cardiac dysfunction (dyspnoea, palpitations, fatigue, hypotension), elevated troponin, and global left ventricular hypokinesia, especially with a febrile illness and rapid recovery, are <strong>highly suggestive of viral myocarditis</strong>. <strong>Coxsackie virus is a predominant viral etiology</strong> for this condition.</p>",
      "correct_choice_id": 134,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15,
      "choices": [
        {
          "id": 141,
          "text": "<p><span style=\"font-size:12.0pt;\">Alcohol Septal Ablation</span></p>"
        },
        {
          "id": 142,
          "text": "<p><span style=\"font-size:12.0pt;\">Disopyramide</span></p>"
        },
        {
          "id": 143,
          "text": "<p><span style=\"font-size:12.0pt;\">Beta Blocker</span></p>"
        },
        {
          "id": 144,
          "text": "<p><span style=\"font-size:12.0pt;\">Implantable Defibrillator</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 27-year-old man who is known to have Hypertrophic Cardiomyopathy has an out of hospital cardiac arrest and is successfully resuscitated. What is the most appropriate mode of treatment? </span></p>",
      "unique_key": "DT1190649",
      "question_audio": null,
      "question_video": null,
      "map_id": 1190649,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<ul>\r\n<li>The patient has <strong>Hypertrophic Cardiomyopathy (HCM)</strong> and has experienced an <strong>out-of-hospital cardiac arrest (OHCA)</strong> with successful resuscitation. This is a <strong>class I indication for an Implantable Cardioverter Defibrillator (ICD).</strong></li>\r\n<li>Patients with HCM are at an <strong>increased risk of sudden cardiac death (SCD)</strong> primarily due to ventricular fibrillation (VF) or sustained ventricular tachycardia (VT). An OHCA due to VF/VT is the <strong>strongest secondary prevention indication for ICD implantation</strong>.</li>\r\n<li>ICDs are highly effective in <strong>detecting and terminating life-threatening ventricular arrhythmias</strong>, thereby preventing recurrent sudden cardiac death. They are considered <strong>superior to antiarrhythmic drugs like amiodarone or beta-blockers</strong> for preventing SCD in high-risk HCM patients.</li>\r\n<li>Other indications for ICD implantation include\r\n<ul>\r\n<li>Cardiac arrest due to VF/VT</li>\r\n<li>Sustained VT causing haemodynamic compromise</li>\r\n<li>Chronic Heart Failure, LVEF&lt;40% and associated syncopal episodes due to Non Sustained VT</li>\r\n<li>Arrhythmogenic right ventricular cardiomyopathy causing cardiac arrest</li>\r\n<li>Congenital Long QT with family history of sudden cardiac death at young age</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>Explanation of Other Options:</strong></p>\r\n<p><strong>Alcohol Septal Ablation (Option A):</strong> Alcohol septal ablation is a <strong>catheter-based procedure</strong> used to <strong>reduce left ventricular outflow tract (LVOT) obstruction</strong> and alleviate severe symptoms.</p>\r\n<p><strong>Disopyramide (Option B):</strong> Disopyramide is a <strong>Class Ia antiarrhythmic drug</strong> with negative inotropic properties, used in the <strong>medical management of symptomatic HCM</strong> to reduce obstruction.</p>\r\n<p><strong>Beta Blocker (Option C):</strong> Beta-blockers are a <strong>cornerstone of medical management for symptomatic HCM</strong>, reducing myocardial contractility and relieving outflow tract obstruction.</p>\r\n<p><strong>Key Takeaway:</strong> For patients with Hypertrophic Cardiomyopathy (HCM) who have experienced a <strong>cardiac arrest or sustained ventricular tachycardia/fibrillation, an Implantable Cardioverter Defibrillator (ICD) is the most appropriate and life-saving mode of treatment</strong> for secondary prevention of sudden cardiac death.</p>",
      "correct_choice_id": 144,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16,
      "choices": [
        {
          "id": 151,
          "text": "<p><span style=\"font-size:12.0pt;\">Takotsubo cardiomyopathy</span></p>"
        },
        {
          "id": 152,
          "text": "<p><span style=\"font-size:12.0pt;\">Arrhythmogenic right ventricular cardiomyopathy</span></p>"
        },
        {
          "id": 153,
          "text": "<p><span style=\"font-size:12.0pt;\">Acute Myocarditis</span></p>"
        },
        {
          "id": 154,
          "text": "<p><span style=\"font-size:12.0pt;\">MI due to left anterior descending coronary artery occlusion</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 65 year old female presented to the emergency department with chest discomfort and breathlessness after she heard the news about the demise of her husband. She had no fever, hypotension or syncope. ECG was suggestive of anterolateral wall ischemia. ECHO showed global ventricular dilation with ballooning of apex and basal contraction. What is the likely diagnosis? </span></p>",
      "unique_key": "DT1190651",
      "question_audio": null,
      "question_video": null,
      "map_id": 1190651,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<ul>\r\n<li>The patient's presentation of <strong>chest discomfort and breathlessness following an acute emotional stressor (demise of her husband)</strong>, coupled with <strong>ECG changes suggestive of anterolateral wall ischemia</strong> and an echocardiogram showing <strong>global ventricular dilation with characteristic \"ballooning of the apex and basal contraction,\"</strong> is highly indicative of <strong>Takotsubo cardiomyopathy </strong>.</li>\r\n<li>Takotsubo cardiomyopathy, also known as stress-induced cardiomyopathy or apical ballooning syndrome, is characterized by a <strong>transient dysfunction of the left ventricle</strong> that mimics myocardial infarction but occurs in the absence of significant coronary artery disease. The distinctive echocardiographic finding of apical ballooning with preserved basal function gives the ventricle a shape resembling a Japanese octopus trap, or 'takotsubo'.</li>\r\n</ul>\r\n<p><strong>Explanation of Other Options:</strong> <strong>Arrhythmogenic right ventricular cardiomyopathy (Option B):</strong> ARVC is a <strong>genetic disorder</strong> where the <strong>right ventricular myocardium is progressively replaced by fibrofatty tissue</strong>. This leads to right ventricular dysfunction and arrhythmias originating from the right ventricle.</p>\r\n<p><strong>Acute Myocarditis (Option C):</strong> Acute myocarditis is an <strong>inflammation of the heart muscle</strong>, often caused by viral infections. It typically presents with <strong>fever</strong>, chest pain, dyspnoea, ECG changes, and global ventricular hypokinesia.</p>\r\n<p><strong>MI due to left anterior descending coronary artery occlusion (Option D):</strong> An MI due to LAD occlusion causes <strong>anterolateral wall ischemia and segmental wall motion abnormalities</strong> in the LAD territory. This is due to a significant coronary artery blockage.</p>\r\n<p><strong>Key Takeaway:</strong> <strong>Takotsubo cardiomyopathy (stress-induced cardiomyopathy)</strong> is characterized by <strong>transient left ventricular dysfunction with apical ballooning and basal hyperkinesis</strong> that typically follows a <strong>severe emotional or physical stressor</strong>, mimicking an acute myocardial infarction.</p>",
      "correct_choice_id": 151,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 17,
      "choices": [
        {
          "id": 161,
          "text": "<p><span style=\"font-size:12.0pt;\">Restrictive cardiomyopathy</span></p>"
        },
        {
          "id": 162,
          "text": "<p><span style=\"font-size:12.0pt;\">Alcoholic cardiomyopathy</span></p>"
        },
        {
          "id": 163,
          "text": "<p><span style=\"font-size:12.0pt;\">Arrhythmogenic right ventricular cardiomyopathy</span></p>"
        },
        {
          "id": 164,
          "text": "<p><span style=\"font-size:12.0pt;\">Takotsubo cardiomyopathy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The cardiomyopathy characterised by fibrofatty replacement of the myocardium is: </span></p>",
      "unique_key": "DT1190653",
      "question_audio": null,
      "question_video": null,
      "map_id": 1190653,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<ul>\r\n<li><strong>Arrhythmogenic right ventricular cardiomyopathy (ARVC) (Option C)</strong> is a <strong>genetically determined cardiomyopathy</strong> specifically characterized by the <strong>progressive fibrofatty replacement of the myocardium</strong>, predominantly affecting the right ventricle.</li>\r\n<li>This replacement involves the <strong>transformation of myocytes into adipocytes and fibrous tissue</strong>, which can lead to ventricular arrhythmias, heart failure, and sudden cardiac death.</li>\r\n<li>ARVC is associated with defects in desmosomal proteins, leading to abnormal cell signaling and structural integrity.</li>\r\n</ul>\r\n<p><strong>Explanation of Other Options:</strong></p>\r\n<p><strong>Restrictive cardiomyopathy (Option A):</strong> Restrictive cardiomyopathy is characterized by <strong>impaired ventricular filling due to stiff, non-compliant myocardium</strong>, often caused by infiltrative processes like amyloidosis or hemochromatosis, but <strong>not primarily by fibrofatty replacement</strong>.</p>\r\n<p><strong>Alcoholic cardiomyopathy (Option B):</strong> Alcoholic cardiomyopathy is a type of <strong>dilated cardiomyopathy</strong> that results from <strong>chronic, heavy alcohol consumption</strong>, leading to ventricular dilation and systolic dysfunction, without specific fibrofatty replacement.</p>\r\n<p><strong>Takotsubo cardiomyopathy (Option D):</strong> Takotsubo cardiomyopathy, or stress-induced cardiomyopathy, involves <strong>transient left ventricular dysfunction</strong> (apical ballooning) typically triggered by emotional or physical stress, and is not characterized by fibrofatty replacement of the myocardium.</p>\r\n<p><strong>Key Takeaway:</strong> <strong>Arrhythmogenic right ventricular cardiomyopathy (ARVC)</strong> is uniquely defined by the <strong>progressive fibrofatty replacement of the myocardium</strong>, predominantly in the right ventricle, leading to arrhythmias and heart failure.</p>",
      "correct_choice_id": 163,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18,
      "choices": [
        {
          "id": 171,
          "text": "<p><span style=\"font-size:12.0pt;\">Thiamine</span></p>"
        },
        {
          "id": 172,
          "text": "<p><span style=\"font-size:12.0pt;\">Pyridoxine</span></p>"
        },
        {
          "id": 173,
          "text": "<p><span style=\"font-size:12.0pt;\">Selenium</span></p>"
        },
        {
          "id": 174,
          "text": "<p><span style=\"font-size:12.0pt;\">Carnitine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following nutrient deficiencies is not associated with dilated cardiomyopathy?</span></p>",
      "unique_key": "DT1231853",
      "question_audio": null,
      "question_video": null,
      "map_id": 1231853,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<ul>\r\n<li><strong>Pyridoxine (Vitamin B6) deficiency (Option B)</strong> is <strong>not typically associated with the development of dilated cardiomyopathy (DCM)</strong>. Pyridoxine deficiency can lead to various symptoms including peripheral neuropathy, sideroblastic anemia, and skin lesions.</li>\r\n<li><strong>Thiamine (Vitamin B1) deficiency (Option A)</strong> is well-known to cause <strong>\"wet beriberi\"</strong>, a form of high-output cardiac failure that can present as dilated cardiomyopathy.</li>\r\n<li><strong>Selenium deficiency (Option C)</strong> is associated with <strong>Keshan disease</strong>, an endemic cardiomyopathy characterized by multifocal myocardial necrosis and fibrosis, presenting as dilated cardiomyopathy.</li>\r\n<li><strong>Carnitine deficiency (Option D)</strong> can impair fatty acid metabolism in the myocardium, leading to <strong>dilated cardiomyopathy</strong>, especially in pediatric populations.</li>\r\n<li>Other nutrient deficiencies that have been linked to DCM include taurine and niacin. Electrolyte abnormalities like hypocalcemia and hypophosphatemia are also associated.</li>\r\n</ul>\r\n<p><strong>Key Takeaway:</strong></p>\r\n<p>While deficiencies of <strong>thiamine, selenium, and carnitine</strong> are known causes of dilated cardiomyopathy, <strong>pyridoxine (Vitamin B6) deficiency</strong> is primarily associated with neurological and hematological issues, <strong>not dilated cardiomyopathy</strong>.</p>",
      "correct_choice_id": 172,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}